Astrazeneca (AZN) Total Debt (2016 - 2025)
Historic Total Debt for Astrazeneca (AZN) over the last 17 years, with Q4 2025 value amounting to -$38.2 billion.
- Astrazeneca's Total Debt fell 1596.74% to -$38.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$38.2 billion, marking a year-over-year decrease of 1596.74%. This contributed to the annual value of -$38.2 billion for FY2025, which is 1596.74% down from last year.
- Astrazeneca's Total Debt amounted to -$38.2 billion in Q4 2025, which was down 1596.74% from -$41.0 billion recorded in Q3 2025.
- In the past 5 years, Astrazeneca's Total Debt ranged from a high of $29.8 billion in Q4 2021 and a low of -$43.7 billion during Q3 2021
- In the last 5 years, Astrazeneca's Total Debt had a median value of -$33.6 billion in 2022 and averaged -$25.1 billion.
- Per our database at Business Quant, Astrazeneca's Total Debt surged by 21710.0% in 2021 and then tumbled by 21988.43% in 2024.
- Astrazeneca's Total Debt (Quarter) stood at $29.8 billion in 2021, then dropped by 5.08% to $28.3 billion in 2022, then dropped by 2.78% to $27.5 billion in 2023, then tumbled by 219.88% to -$33.0 billion in 2024, then dropped by 15.97% to -$38.2 billion in 2025.
- Its Total Debt was -$38.2 billion in Q4 2025, compared to -$41.0 billion in Q3 2025 and -$24.7 billion in Q2 2025.